Targeting of Aberrant avß6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells. (2017)

First Author: Whilding LM
Attributed to:  King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ymthe.2016.10.012

PubMed Identifier: 28129120

Publication URI: http://europepmc.org/abstract/MED/28129120

Type: Journal Article/Review

Volume: 25

Parent Publication: Molecular therapy : the journal of the American Society of Gene Therapy

Issue: 1

ISSN: 1525-0016